FOXM1 and neoplasm: Furthermore, both compounds showed good pharmacokinetics and long half-lives in mice after s.c. administration [11], and they suppressed breast tumor xenograft growth and the expression of tumor FOXM1-regulated genes [11] and tumor metastasis [8].